Adaptive Designs in Clinical Trials 2018
In-Person Event
Apr 09 - 11, 2018
London, England, GB
OVERVIEW
Adaptive Designs in Clinical Trials is organized by SMi Group and will be held during Apr 09 - 11, 2018 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.
The target audience for this medical event is Biostatisticians, Clinical project managers, Clinical research advisors, Clinical Trials Directors, Clinical scientists, Statisticians.
With recent continuous developments in biotechnology, genomics and medicine, there is a high demand for more innovative and adaptive ways to design drug development programs.With adaptive design protocols becoming ever more complex, Adaptive Designs in Clinical Trials 2018 will equip you with the latest knowledge about the changing attitudes of the regulatory bodies to adaptive designs, how technology and experimental approaches will enrich your adaptive trials and how to ameliorate risks and errors in your adaptive designs.
This conference will continue the discussion on recent developments and applications of state-of-the-art adaptive design techniques in clinical research. Experienced industry experts from across the globe will discuss recent real-life applications of group sequential and adaptive enrichment designs and give presentations on confirmatory designs with treatment selection and the use of basket, umbrella and platform studies in personalised medicine. Updates on the regulatory aspects and the evaluation of the use of new digital technologies in adaptive trials will also expand your knowledge of the current outlook in adaptive designs.
Benefits of attending
• Hear exciting case studies on enrichment designs and group sequential trials from Boehringer-Ingelheim, Sanofi Aventis and H.lundbeck
• Explore the current industry outlook and evaluate the promises and challenges of digital technology use with Amgen and Novartis
• Discover how AstraZeneca and UCB Pharma are using Platform Trials and self adapting priors to advance their adaptive clinical trials
• Examine how Roche and Merck KGaA are using adaptive clinical trials to produce targeted therapies
Prices:
Conference Only: GBP 1499,
1 Workshop Only: GBP 599,
Full Package (Conf and x2 Workshops): GBP 2697,
Other Packages Available: GBP 0
Speakers: Alex Sverdlov, James Matcham, Christine Fletcher, Chris Horbron, Frank Fleischer, Ros Walley, Plus many more...
Additional details will be posted as soon as they are available.
The target audience for this medical event is Biostatisticians, Clinical project managers, Clinical research advisors, Clinical Trials Directors, Clinical scientists, Statisticians.
With recent continuous developments in biotechnology, genomics and medicine, there is a high demand for more innovative and adaptive ways to design drug development programs.With adaptive design protocols becoming ever more complex, Adaptive Designs in Clinical Trials 2018 will equip you with the latest knowledge about the changing attitudes of the regulatory bodies to adaptive designs, how technology and experimental approaches will enrich your adaptive trials and how to ameliorate risks and errors in your adaptive designs.
This conference will continue the discussion on recent developments and applications of state-of-the-art adaptive design techniques in clinical research. Experienced industry experts from across the globe will discuss recent real-life applications of group sequential and adaptive enrichment designs and give presentations on confirmatory designs with treatment selection and the use of basket, umbrella and platform studies in personalised medicine. Updates on the regulatory aspects and the evaluation of the use of new digital technologies in adaptive trials will also expand your knowledge of the current outlook in adaptive designs.
Benefits of attending
• Hear exciting case studies on enrichment designs and group sequential trials from Boehringer-Ingelheim, Sanofi Aventis and H.lundbeck
• Explore the current industry outlook and evaluate the promises and challenges of digital technology use with Amgen and Novartis
• Discover how AstraZeneca and UCB Pharma are using Platform Trials and self adapting priors to advance their adaptive clinical trials
• Examine how Roche and Merck KGaA are using adaptive clinical trials to produce targeted therapies
Prices:
Conference Only: GBP 1499,
1 Workshop Only: GBP 599,
Full Package (Conf and x2 Workshops): GBP 2697,
Other Packages Available: GBP 0
Speakers: Alex Sverdlov, James Matcham, Christine Fletcher, Chris Horbron, Frank Fleischer, Ros Walley, Plus many more...
Additional details will be posted as soon as they are available.
KEY DATES
09 Apr, 2018
Event Start Date
11 Apr, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineResearch and Clinical ResearchSUGGESTED HOTELS
CONFERENCE VENUE
Copthorne Tara Hotel London KensingtonRELATED CONFERENCES & LIVE WEBINARS
Quick Links